*ECT2* amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma
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Adenocarcinoma of the lung represents the most common cause of cancer-related death in many countries, including Japan. There are few biomarkers to serve as prognostic factors when evaluating patients with lung cancer. In their exciting work, Murata and coworkers analyzed specimens from both *in situ* and invasive lung adenocarcinomas and compared these two types of tissues for prognostic biomarkers. With cutting-edge technologies the authors identified the epithelial cell transforming sequence 2 oncogene (*ECT2*) as a marker of invasive adenocarcinoma. Of great importance, overexpression of *ECT2* was correlated with patient survival and this result was confirmed in a second, independent set of lung cancer specimens. Results from this study indicate that the oncogene *ECT2* might serve as an important biomarker for disease prognosis in adenocarcinoma of the lung.
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*MKK7* mediates microRNA-493-dependent suppression of liver metastasis of colon cancer cells
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Colon cancer is one of the leading cancers worldwide and metastatic disease portends a very poor prognosis. The liver is the most common site of metastases from colon cancer and Sakai and colleagues have previously found that an endogenous microRNA, miR-493, acts to suppress metastatic disease to the liver. In their current work, the authors sought to further elucidate the molecular mechanisms by which miR-493 exerts its positive effect. Using siRNA, they identified *MKK7* as an important molecular target of miR-493. These results reveal in greater detail how miR-493 acts to suppress the occurrence of liver metastases in colon cancer. In addition to advancing the understanding of this important molecular cascade, the authors\' findings suggest another potential molecular target for therapeutic interventions in this deadly disease.
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Context-dependent activation of Wnt signaling by tumor suppressor *RUNX3* in gastric cancer cells
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In this interesting study, Ju and colleagues uncovered a new role of the well-studied *RUNX3* tumor suppressor. Previously, it was thought that *RUNX3* worked to inhibit the Wnt signaling pathway by blocking a complex that activates Wnt gene transcription. What Ju et al. found is that, although this is correct in certain human gastric cancer cell lines, in the KatoIII gastric cancer cell lines *RUNX3* actually stabilizes, not inhibits, the promoter complex, leading to an activation of Wnt. Even more fascinating is that while Wnt expression was increased with *RUNX3* expression, there was *still* an overall tumor suppressor effect. This suggests two novel roles for *RUNX3*: first, it can either stabilize or inhibit Wnt promoter complexes, leading to the activation or suppression of Wnt expression; and second, *RUNX3* has tumor suppressor effects that operate independently of Wnt.
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